Novel Bio

Novel Bio is a biotechnology company focused on advanced plasmid DNA (pDNA) manufacturing, particularly for applications in gene therapy, mRNA, and CRISPR research. The company utilizes a next-generation microbial platform to enhance production capabilities and overcome traditional limitations in the industry. Novel Bio aims to set new standards in biotech by engineering superior microbial strains for scalable, high-quality pDNA production.

The team at Novel Bio consists of experts in DNA manufacturing, dedicated to addressing challenges in genetic medicine development. They emphasize personalized service and innovative engineering, branding their approach as "A Better Way To DNA." The company is privately held and is currently in a key commercialization phase, actively partnering with leading companies to accelerate the development of therapies for patients. Their core offering includes GMP-grade plasmid DNA production, supported by a commitment to efficient scaling and high-quality manufacturing.